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Abstract
Numerous local interventions for cardiovascular disease 
are available, but resources to deliver them are limited. 
Identifying  the  most  effective  interventions  is  challeng-
ing because cardiovascular risks develop through causal 
pathways  and  gradual  accumulations  that  defy  simple 
calculation. We created a simulation model for evaluating 
multiple approaches to preventing and managing cardio-
vascular risks. The model incorporates data from many 
sources to represent all US adults who have never had 
a  cardiovascular  event.  It  simulates  trajectories  for  the 
leading direct and indirect risk factors from 1990 to 2040 
and evaluates 19 interventions. The main outcomes are 
first-time  cardiovascular  events  and  consequent  deaths, 
as well as total consequence costs, which combine medi-
cal  expenditures  and  productivity  costs  associated  with 
cardiovascular events and risk factors. We used sensitivity 
analyses to examine the significance of uncertain param-
eters. A base case scenario shows that population turn-
over and aging strongly influence the future trajectories 
of several risk factors. At least 15 of 19 interventions are 
potentially cost saving and could reduce deaths from first 
cardiovascular  events  by  approximately  20%  and  total 
consequence costs by 26%. Some interventions act quickly 
to reduce deaths, while others more gradually reduce costs 
related to risk factors. Although the model is still evolving, 
the simulated experiments reported here can inform policy 
and spending decisions.
Introduction
Conditions in particular neighborhoods or cities can pro-
foundly enhance or impede people’s prospects for a healthy 
life (1). This dependence on local context is especially evi-
dent in cardiovascular health, for which behavioral, social, 
and environmental factors combine to affect the likelihood 
of developing disease or dying prematurely (2). Heart dis-
ease and stroke are largely preventable, but they remain 
the first and third leading causes of death in the United 
States, partly because we have yet to establish living con-
ditions that minimize such modifiable risks as smoking, 
obesity, stress, air pollution, poor diet, and physical inac-
tivity. The importance of intervening to limit these risks 
is highlighted in A Public Health Action Plan to Prevent 
Heart Disease and Stroke (3).
The  notion  that  cardiovascular  disease  (CVD)  can  be 
prevented through local actions raises practical questions 
that can be examined through systems modeling and sim-
ulation. Working closely with colleagues in Austin/Travis 
County, Texas, and subject matter experts at the Centers 
for  Disease  Control  and  Prevention  and  the  National 
Institutes  of  Health,  we  developed  a  system  dynamics 
simulation model to answer the following questions:
• How does local context affect the major risk factors for 
CVD and, in turn, population health status and costs?
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• How might local interventions affect CVD risk, health 
status, and costs over time?
• How  might  local  health  leaders  better  balance  their 
policy efforts given limited resources?
Methods
System dynamics models improve our ability to antici-
pate  the  likely  effects  of  interventions  in  dynamically 
complex situations, where the pathways from interven-
tions to outcomes may be indirect, delayed, and possibly 
affected by nonlinearities or feedback loops (4). System 
dynamics  has  been  used  effectively  since  the  1970s  to 
model  many  areas  of  public  health  and  social  policy, 
including CVD (5).
Model structure
We previously described a framework for understanding 
cardiovascular health in a local context (6). That frame-
work has been refined and quantified by using additional 
literature  and  input  from  veteran  health  planners  and 
analysts. The resulting simulation model (Figure 1) focus-
es on primary prevention; it does not address people who 
have experienced a CVD event. Causal influences move 
down and to the right, ending with 2 outcomes: 1) first-
time cardiovascular events and consequent deaths and 2) 
Figure 1. Simulation model for cardiovascular disease (CVD) outcomes. This diagram depicts major health conditions related to CVD and their causes. Boxes 
identify risk factor prevalence rates modeled as dynamic stocks. The population flows associated with these stocks — including people entering the adult popu-
lation, entering the next age category, immigration, risk factor incidence, recovery, cardiovascular event survival, and death — are not shown. 
 
Key: 
Blue solid arrows: causal linkages affecting risk factors and cardiovascular events and deaths. 
Brown dashed arrows: influences on costs. 
Purple italics: factors amenable to direct intervention. 
Black italics (population aging, cardiovascular event fatality): other specified trends. 
Black nonitalics: all other variables, affected by italicized variables and by each other.VOLUME 7: NO. 1
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costs associated with these events and with the identified 
risk factors.
The model starts with conditions in the United States in 
1990 and simulates them continuously through 2040. The 
population without CVD and risk factor prevalence rates 
are represented as dynamic stock or state variables, sub-
divided by sex and age group (18-29 y, 30-64 y, and ≥65 y). 
Smoking and obesity are viewed as reversible conditions, 
whereas diabetes, high blood pressure, and high cholester-
ol are viewed as chronic conditions that are not reversible 
but that can be controlled, with the help of good-quality 
primary health care, to reduce CVD risk.
The incidence of first-time CVD events in the model is 
driven by the effect of several direct risk factors, based on 
a widely used risk calculator from the Framingham Heart 
Study  (7).  We  modified  that  calculator  in  several  ways 
for this study, most fundamentally by estimating annual 
risks  at  a  population  level  on  the  basis  of  risk  factor 
prevalence rates, rather than at the level of an individual. 
(A detailed description of the modified calculator is avail-
able  at  http://sustainer.org/cvd/documents/SELI_App1.
pdf). We also recognized the direct effect on CVD events, 
especially myocardial infarctions, from secondhand smoke 
and small particulate matter (PM 2.5) air pollution (8-11). 
Furthermore,  because  deaths  from  CVD  have  declined 
partly because of improvements in emergency and acute 
care, we incorporated a downward trend in the CVD case-
fatality rate for 1990 through 2003 (12).
Obesity contributes to CVD, largely through diabetes, 
high blood pressure, and high cholesterol levels (13). Other 
indirect influences in the model are physical inactivity, 
poor diet, psychosocial stress, and smoking as it affects 
diabetes and obesity (14-21).
Both  the  direct  and  indirect  influences  in  the  model 
may be modified by 19 interventions (Table 1). These 19 
interventions could be implemented at a city, county, or 
state  level  rather  than  requiring  changes  nationwide. 
In functional terms, the interventions are of a few basic 
types: those that provide broader access to health-promot-
ing services, those that promote desirable behaviors, and 
those that tax or regulate to deter undesirable behaviors.
Cost calculation
We used a common metric — constant 2005 dollars — to 
track  medical  and  productivity  costs  (for  morbidity  and 
mortality) that might be affected by the 19 interventions. 
We measured the societal value of morbidity (sick days) 
and premature mortality (years of life lost) using a human 
capital approach, which estimates the market value of lost 
productivity at work and at home (22). (A detailed descrip-
tion of cost calculations is available at http://sustainer.org/
cvd/documents/SELI_App2.pdf.) This summary of medical 
and productivity costs can determine whether any inter-
vention, or package of interventions, is justified by its likely 
aggregate consequences, or “total consequence costs.” We 
did not estimate the costs of interventions. However, the 
total consequence costs can inform spending decisions. For 
example, suppose that for a given intervention the model 
calculates a total consequence cost savings of $50 per cap-
ita. Planners may then conclude that up to $50 per capita 
could be justifiably spent to implement that intervention 
and still create positive net benefits to society.
The model tracks 3 types of intervention consequences:
• Medical and productivity costs attributable to fatal and 
nonfatal CVD events.
• Medical and productivity costs attributable to noncar-
diovascular complications of smoking (eg, lung cancer), 
diabetes (eg, blindness), high blood pressure (eg, kidney 
failure), and obesity (eg, colorectal cancer). We have thus 
far been able to quantify these costs, but not yet the costs 
related to noncardiovascular complications of stress (eg, 
depression), physical inactivity (eg, back pain), or poor 
diet (eg, colorectal cancer).
• Costs of services and products to manage risk factors. 
These  include  medications  and  visits  for  managing 
chronic  disorders,  mental  health  services,  weight-loss 
services, and smoking cessation services and products.
Model calibration
Although the model is meant to investigate interven-
tions in localities such as Austin/Travis County, we began 
by  calibrating  it  to  represent  the  entire  United  States. 
This approach enabled more precise estimation, given that 
certain data were either unreliable or unavailable at the 
local level. The results are generally reported as per capita 
estimates to facilitate interpretation at a local level. Table 
2 lists the major information sources on which the model 
is based (23-32).
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smoking, obesity, diabetes, high blood pressure, and high 
cholesterol,  as  well  as  cessation  rates  for  smoking  and 
obesity. These parameters have been set so that the model 
accurately simulates the observed changes in prevalence 
rates in the National Health and Nutrition Examination 
Survey from 1988-1994 to 1999-2004.
The model also contains 56 causal links requiring the 
estimation of relative risks, effect sizes, or initial values. 
Many of these parameters were estimated through the use 
of published studies, meta-analyses, and in some instanc-
es, ad hoc surveys of veteran practitioners (33). Because 
most  of  these  parameter  estimates  have  some  level  of 
uncertainty, we also identified lower and upper bounds to 
be used for sensitivity analysis.
Model testing
Having  calibrated  the  model  to  accurately  reproduce 
observed  trends  in  risk  factor  prevalence  rates  as  well 
as  CVD  events  and  deaths,  we  then  explored  plausible 
futures. A base case scenario assumed no changes after 
2004  in  many  of  the  local  determinants  of  risk  in  the 
adult population, including healthiness of diet, extent of 
physical activity, stress, use of quality primary care, air 
pollution, and the prevalence rates of smoking and obesity 
among incoming 18-year-olds. This base case should not 
be taken as a statement about what is most likely to hap-
pen in the absence of intervention, but rather serves as a 
straightforward and easily understood benchmark against 
which to compare intervention scenarios.
We tested interventions singly and in groups of similar 
interventions. For all interventions, we assumed a 1-year 
ramp-up  during  2009,  followed  by  full  implementation 
from 2010 through 2040. The significance of full imple-
mentation depends on the intervention, but in all cases is 
based on effect sizes that the research literature or veteran 
practitioners indicate should be possible:
• For  the  7  marketing  interventions  and  for  taxes  on 
tobacco or junk food: doing the maximum that has been 
demonstrated or seriously proposed somewhere in the 
United States.
• For the 6 access interventions: raising access to 100%.
• For smoking restriction: reducing secondhand exposures 
in workplaces and public places to zero.
• For air pollution: reducing small particulate matter by 
50% from its 2001-2003 value.
• For sources of chronic stress: a 50% reduction.
• For the quality of primary care (ie, adherence to guide-
lines): improvement from a national average of 54% (27) 
to 75%.
For  each  intervention  scenario,  we  conducted  separate 
simulations using the midpoint, lower-end, and upper-end 
values for all uncertain parameters. This method yielded a 
range of plausible outcomes for each intervention scenario.
Discussion
Base case results
The base case projects that even after 2004, when we 
assume no further changes to the model’s inputs, histori-
cal trends in the model’s risk factor prevalence rates will 
continue through 2040, although with diminishing slopes. 
In particular, the model projects further declines in smok-
ing  (and,  thus,  secondhand  smoke  exposure)  and  high 
cholesterol, and at the same time further growth in high 
blood pressure and diabetes. The projected continuation of 
past trends reflects the eventual death of older cohorts and 
their replacement by younger cohorts with different habits 
and  characteristics.  For  instance,  the  continued  decline 
of smoking prevalence reflects the lower rate of smoking 
among  teens  and  young  adults  today  than  in  previous 
decades.  Such  demographic  turnover  also  helps  explain 
the continued growth of high blood pressure and diabetes, 
which occurs in the model as a legacy of the increase in 
obesity — a leading risk factor for both disorders — from 
1980 to 2004. The projected continuation of trends also 
reflects  the  future  aging  of  the  population;  the  over-65 
population  will  increase  from  2010  through  2030.  This 
aging effect contributes to the projected decline in smoking 
because smoking is much less common among the elderly. 
It also contributes to the projected increase in high blood 
pressure and diabetes because the prevalence of these dis-
orders is higher with increasing age.
Deaths from first-time CVD events, which declined by 
35%  from  1990  to  2004,  are  projected  in  the  base  case 
to rebound by 33% from 2004 to 2040. Much of the past 
decline  is  attributable  to  a  28%  reduction  in  the  event 
fatality rate, from improvements in emergency and acute 
care.  But  it  also  reflects  an  11%  decline  in  the  rate  of 
CVD events that occurred, despite increases in high blood 
pressure and diabetes, because of decreases in smoking, VOLUME 7: NO. 1
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secondhand smoke, PM 2.5 air pollution, and uncontrolled 
high cholesterol.
The potential future rebound in deaths anticipated by 
our model reflects a 17% increase in fatality from CVD 
events per capita and a 15% increase in the rate of CVD 
events because of the aging of the population. Although 
the base case projects no future increase in CVD events or 
deaths within each age group, the aging of the population 
will lead to an increase in the overall rate of CVD events 
and deaths.
Per  capita  total  consequence  costs,  which  the  model 
calculates to have declined by 25% from 1990 to 2004, are 
projected in the base case to decline by another 5% from 
2004 to 2040. Total consequence costs encompass not only 
CVD events (which account for 44% of the total costs in 
2004)  but  also  noncardiovascular  complications  of  risk 
factors (also 44%) and management of risk factors (12%). 
Although  per  capita  CVD  event  costs  are  projected  to 
increase by 12% from 2004 to 2040 (reflecting the increase 
in the frequency of the events themselves) and per capita 
risk management costs are projected to increase by 8% 
(reflecting  the  growing  demand  for  blood  pressure  and 
diabetes treatment), these increases are more than offset 
by  a  25%  decrease  in  noncardiovascular  complications. 
This decrease is due to the projected decline of smoking, 
which  in  2004  was  responsible  for  more  than  400,000 
noncardiovascular deaths, primarily from lung cancer and 
chronic obstructive pulmonary disease. These premature 
non-CVD deaths from smoking account for a large fraction 
(about 28% in 2004) of the total consequence costs calcu-
lated in the model.
Intervention scenario results
Individual  tests  of  the  19  interventions  suggest  that 
each can reduce deaths from first-time CVD events, and 
most  can  reduce  total  consequence  costs.  Four  of  the 
interventions,  however,  raise  total  consequence  costs, 
meaning that they increase risk factor management costs 
more than they decrease the costs of medical events and 
complications.  These  4  interventions  include  the  2  that 
encourage use of mental health services and the 2 that 
encourage use of weight-loss services. However, because 
of limitations in the model, planners should not dismiss 
these interventions in the real world. In the case of mental 
health  services,  we  have  not  yet  estimated  the  noncar-
diovascular costs of depression. In the case of weight-loss 
services for obese people, our estimates of cost and benefit 
are based on conventional dieting and exercise programs, 
rather than on bariatric surgery, which, although more 
costly, also appears to be more effective (34).
We present simulation results for only the 15 interven-
tions that in the model do not increase total consequence 
costs (Figure 2). Such a multipronged approach may be 
challenging to implement, given resource limitations, but 
it is useful to look at what could be achieved.
The model suggests that if all risk factors in the model 
were eliminated, the death rate could be reduced by approx-
imately 60% below the base case, which falls between the 
50% to 75% rate that other authors have suggested (35). 
This model dichotomizes blood pressure, cholesterol, and 
diabetes as “high” or “not high” and does not further sub-
divide the “not high” into normal and borderline. Reducing 
borderline conditions (prehypertension, borderline choles-
terol, prediabetes) to normal could further reduce CVD, 
but we cannot explore this possibility with this model. (A 
static analysis of the potential benefits of reducing both 
high and borderline conditions is available at http://sus-
tainer.org/cvd/documents/SELI_App3.pdf.)
The  model  projects  that  a  15-component  intervention 
could  reduce  the  first-time  CVD  event  death  rate  rela-
tive to the base case by 20% (range based on sensitivity 
analysis, 15%-26%) in 2015 and by 19% (range, 14%-25%) 
in 2040. Thus, the interventions that could reduce CVD 
deaths have a relatively rapid effect.
The  effect  of  the  interventions  is  more  gradual  with 
regard to total consequence costs than it is with regard 
to  CVD  deaths;  nearly  40%  of  the  eventual  effect  on 
costs occurs after 2015 (Figure 2). If all risk factors in 
the  model  were  eliminated,  consequence  costs  could 
be reduced by approximately 80% below the base case. 
Relative to the base run, the 15-component intervention 
reduces consequence costs by 16% (range, 12%-23%) in 
2015, eventually reaching 26% (range, 19%-33%) in 2040. 
The  reduction  in  consequence  costs  is  $348  per  capita 
(range, $254-$514) in 2015 and $565 per capita (range, 
$416-$722) in 2040.
The  15-component  intervention  may  be  better  under-
stood by examining the incremental contributions of its 
components grouped by topical cluster (Figure 3). We used 
the same base case graph as in Figure 2 and then incre-VOLUME 7: NO. 1
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mentally added the following topical clusters:
1) The 3 interventions that improve the use and quality of 
primary care (Care).
2) The 6 interventions related to air quality and smoking 
(Air).
3) The 5 interventions related to improved nutrition and 
physical  activity  and  the  1  intervention  that  would 
reduce sources of stress (Lifestyle).
The relative effects of the clusters are different for CVD 
deaths than they are for total consequence costs. Of the 
3  topical  clusters,  the  largest  contributor  to  projected 
reductions in CVD deaths, both in 2015 and 2040, is Care, 
followed by Air and then a smaller (though growing) con-
tribution from Lifestyle. In contrast, the largest contributor 
to projected cost reductions, both in 2015 and 2040, is Air, 
followed by Lifestyle and then a smaller (and ultimately 
negligible) contribution from Care. The contributions to per 
capita cost reduction in 2015 are $235 from Air, $71 from 
Lifestyle, and $42 from Care. The contributions in 2040 are 
$393 from Air, $165 from Lifestyle, and $7 from Care.
Conclusions
The major factors that affect cardiovascular health at 
a population level interact through causal pathways and 
develop through gradual accumulations that defy simple 
calculation. This dynamic complexity — and not just gaps 
in data — is a challenge for local leaders who want to 
intervene  most  effectively  given  limited  resources.  Our 
simulation model helps meet this challenge by integrating 
what is known about the various risk factors in a single 
testable framework for prospective policy analysis.
The  simulations  reported  here  point  to  several  con-
clusions that local leaders and national allies may find 
valuable. 
1) The CVD death rate has declined in recent years, not 
only because of improvements in emergency and acute care 
but also because of reductions in the CVD event rate itself, 
due to reductions in smoking, secondhand smoke, particu-
late air pollution, and uncontrolled high cholesterol. If this 
progress does not continue at a similar pace in the future, 
however, the CVD death rate will likely rebound strongly 
as the population ages. 
2) Medical and productivity costs associated with CVD 
risk  factors  have  declined  because  of  declines  in  first-
time CVD events and consequent deaths, and because of 
reductions in non-CVD deaths (especially lung cancer and 
chronic  obstructive  pulmonary  disease)  associated  with 
Figure 2. Estimated impacts of a 1-component intervention, with ranges based on sensitivity testing, simulation model for cardiovascular disease (CVD) out-
comes. The 1 interventions are listed in Table 1 under the topical clusters of Care, Air, and Lifestyle. 
 
Key: 
Blue line = base case results. 
Black line = expected reduction in death rate or costs from the 1-component intervention when the uncertain parameters are all set to their baseline values. 
Orange shaded area around the black line = envelope of plausible outcomes in the 1-component intervention outcomes based on sensitivity testing. Upper 
edge (least impact) results when all uncertain impact parameters are set to their lowest values, while lower edge (most impact) results when all uncertain 
impact parameters are set to their greatest values.  
Gray line = the model’s calculation of what the death rate or costs would be if all of the risk factors in the model — smoking, small particulate matter (PM 2.) 
air pollution, high blood pressure, high cholesterol, diabetes, obesity, poor nutrition, inactivity, and stress — were reduced to zero.VOLUME 7: NO. 1
JANUARY 2010
  www.cdc.gov/pcd/issues/2010/jan/08_0231.htm • Centers for Disease Control and Prevention  7
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, the 
Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and 
does not imply endorsement by any of the groups named above.
smoking. Population aging will likely keep smoking preva-
lence on a path of decline into the future, so that even if 
CVD deaths rebound, the total consequence costs need not 
rebound. 
3)  Of  19  interventions  that  local  planners  may  con-
sider for lowering CVD risk, at least 15 could reduce CVD 
deaths without increasing total consequence costs. 
4) Interventions aimed at reducing smoking and improv-
ing indoor and outdoor air quality can save lives relatively 
quickly and can justify intervention spending equivalent to 
as much as $300 per capita per year for 30 years (in 2005 
constant dollars, without time discounting) to achieve the 
full implementation targets. Most local health leaders are 
already aware of the need for tobacco control and smoking 
bans, but many may not be aware of the contribution of 
particulate air pollution to CVD risk, even in areas like 
Austin/Travis County without heavy pollution. 
5) Interventions aimed at improving the use and qual-
ity  of  primary  care  to  diagnose  and  control  high  blood 
pressure,  high  cholesterol,  and  diabetes  can  save  lives 
quickly  but  should  not  be  expected  to  save  much  on 
total costs, primarily because of the high cost of medica-
tions. Consequently, the intervention spending to achieve 
and  maintain  such  improvement  should  not  exceed  the 
equivalent of $25 per capita per year for 30 years. Other 
researchers  have  similarly  found  that  good  preventive 
care for chronic conditions may be cost-effective but is not 
necessarily cost-saving (36,37). 
6) Interventions to improve nutrition and physical activ-
ity and to reduce sources of stress take more time to affect 
CVD deaths, as they gradually reduce obesity and other 
chronic disorders. Nonetheless, their contribution grows 
over time and may justify intervention spending equiva-
lent to as much as $100 per capita per year for 30 years.
The ability of particular localities to achieve full imple-
mentation within these cost limits may vary depending on 
context and implementation factors. Potential extensions 
and improvements to the model include the following:
• Modeling medical and personal costs for the post-CVD 
event  population  and  targeted  interventions  for  sec-
ondary prevention to reduce the rate of recurrent CVD 
events.
• Modeling the prevalence rates of borderline conditions 
(prehypertension,  borderline  cholesterol,  prediabetes) 
and incorporating them in the CVD risk calculations.
• Modeling the prevalence of former smokers and incorpo-
rating their differential risks in the CVD event and cost 
calculations.
Figure 3. Projected changes in the death rate from first-time cardiovascular disease (CVD) events and in total consequence costs per capita when 1 interven-
tions are combined, expressed in terms of clusters of interventions, simulation model for cardiovascular health outcomes. 
 
Key: 
Blue line = base case results. 
Gray line = outcomes if all risk factors were reduced to zero. 
Red line = implement the 3 interventions that improve the use and quality of primary care (Care). 
Green line = add the  interventions related to air quality and smoking (Air). 
Black line = add the  interventions related to improved nutrition and physical activity and the 1 intervention that would reduce sources of stress (Lifestyle). 
This scenario includes all 1 interventions and is identical to the black line in Figure 2.VOLUME 7: NO. 1
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• Incorporating  the  non-CVD  consequences  of  stress, 
physical inactivity, and poor diet.
• Estimating intervention implementation costs to better 
inform intervention priorities.
• Incorporating  additional  independent  risk  factors  for 
CVD (eg, excess sodium intake, excess trans fat intake, 
vitamin D deficiency, periodontal disease).
The model described here was created through a close col-
laboration with health planners in Austin/Travis County, 
who are now using a locally calibrated version of the model 
to support local strategy design and leadership develop-
ment. We plan to pursue similar engagements with col-
leagues elsewhere. With more widespread use, this tool 
may help health planners across the country transform 
local contexts to most effectively improve cardiovascular 
health.
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Tables
Table 1. Interventions Used in Simulation Model for Cardiovascular Health Outcomes, Organized by Topical Cluster
Topical Cluster Intervention
Care Access to affordable primary care 
Promotion of primary care use
Good-quality primary care
Air Tobacco taxes and sales restrictions 
Social marketing against smoking
Access to affordable smoking cessation services and products
Promotion of smoking cessation
Bans on smoking in public places
Regulations and incentives that reduce air pollution
Lifestyle Access to affordable healthy foods 
Promotion of healthy diet
Junk food taxes and sales restrictions
Access to safe and affordable physical activity
Promotion of physical activity
Reduced sources of chronic stress through improved living conditions and social supports
Weight-loss and mental health  
services
Access to affordable weight-loss services for the obese 
Promotion of weight-loss services
Access to affordable mental health services for the chronically stressed
Promotion of mental health servicesVOLUME 7: NO. 1
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Table 2. Information Sources Used in Simulation Model for Cardiovascular Health Outcomes
Topic Source
Population size, growth, and aging, and health care coverage US Census
Rates of cardiovascular events and deaths Reports from American Heart Association (23) and National Institutes of Health 
(12)
Prevalence rates of smoking, obesity, and chronic disorders, and rates 
of diagnosis and control of chronic disorders
National Health and Nutrition Examination Survey (NHANES), 188-1 and 
1-200
Fraction of 18-year-olds who smoke, are obese, or have chronic disor-
ders
NHANES, Youth Risk Behavior Surveillance System
Prevalence of psychosocial stress Behavioral Risk Factor Surveillance System (BRFSS)
Access to and use of good nutrition, physical activity, and primary care BRFSS
Rates of smoking cessation Mendez et al (2), Sloan et al (2)
Rates of people moving from obese to nonobese Homer et al (2)
Trend in fraction of workplaces allowing smoking Surgeon General’s report (11)
Trend in small particulate matter (PM 2.) air pollution Dominici et al ()
Average quality of primary care Asch et al (27)
Medical costs, sick days, and years of life lost due to CVD events and 
deaths
Social Security actuarial life tables, Haddix et al (22), Russell et al (28), Sasser 
et al (2)
Noncardiovascular medical costs and sick days due to smoking, obe-
sity, diabetes, and high blood pressure
Linked files of Medical Examination Panel Survey, National Health Interview 
Survey
Noncardiovascular mortality and years of life lost due to smoking, obe-
sity, diabetes, and high blood pressure
Centers for Disease Control and Prevention Smoking-Attributable Mortality, 
Morbidity, and Economic Costs (SAMMEC), World Health Organization Statistical 
Information System, Flegal et al (30), American Diabetes Association (31), 
Clausen et al (32)